Abstract
Type-2 diabetes mellitus is one of the most prevalent metabolic diseases in the world, and is characterized by hyperglycemia (i.e., high levels of glucose in the blood). Alpha-glucosidases are enzymes in the digestive tract that hydrolyze carbohydrates into glucose. One strategy that has been developed to treat type-2 diabetes is inhibition of the activity of alpha-glucosidases using synthetic drugs. However, these inhibitors are usually associated with gastrointestinal side effects. Therefore, the development of inhibitors from natural products offers an alternative option for the control of hyperglycemia. In recent years, various studies have been conducted to identify alpha-glucosidases inhibitors from natural sources such as plants, and many candidates have transpired to be secondary metabolites including alkaloids, flavonoids, phenols, and terpenoids. In this review, we focus on the alpha-glucosidases inhibitors found in common vegetable crops and the major classes of phytochemicals responsible for the inhibitory activity, and also as potential/natural drug candidates for the treatment of type-2 diabetes mellitus. In addition, possible breeding strategies for production of improved vegetable crops with higher content of the inhibitors are also described.
Keywords: alpha-glucosidase, alpha-glucosidase inhibitor, breeding, diabetes, secondary metabolites, vegetables
1. Introduction
Glycosidases catalyzing the hydrolysis of glycosidic bonds in polysaccharides and glycoconjugates, play critical roles in various biological processes, including carbohydrate digestion, lysosomal catabolism of glycoconjugates, and post-translational modifications of cellular glycoproteins [1,2]. In particular, mammalian α-glucosidase (AG) in the mucosal brush border of the small intestine catalyzes the end step of digestion of starch and disaccharides that are abundant in the human diet. Inhibitors of AG delay the breakdown of carbohydrates in the small intestine and diminish the postprandial blood glucose excursion; thus, inhibition of glycosidases has a significant effect on polysaccharide metabolism, glycoprotein processing, and cellular interaction, widening opportunities for the discovery and development of new therapeutic agents against diseases such as diabetes, obesity, metastatic cancer, and viral infection [3,4]. In particular, AG as a glucosidase located in the brush border of the small intestine is able to selectively hydrolyze terminal (1→4)-linked α-glucose residues (starch or disaccharides) to release a single α-glucose molecule [5,6]. Therefore, various types of potential α-glucosidase inhibitors (AGIs) have been extensively screened or studied and acarbose, miglitol, voglibose, and 1-deoxynojirimycin (DNJ) are currently commercialized anti-glucosidase drugs (Figure 1; [7]) against type-2 diabetes, a chronic condition in which the body becomes resistant to the normal effects of insulin, resulting in ineffectiveness at managing the blood glucose levels.
Most AGIs can attach to the carbohydrate binding site of AG due to their similarity with disaccharides or oligosaccharides in molecular structure. Moreover, the complexes have a stronger affinity than the carbohydrate–glucosidase complexes (Figure 2; [8]). In addition, non-competitive, uncompetitive or mixed types of inhibition of AG activities from some flavonoid-based compounds have been reported (Figure 2; [9]). Thus, inhibition of enzymes involved in the digestion of carbohydrates is able to significantly decrease the postprandial increase of glucose level in the blood after a mixed carbohydrate diet, which has been shown to be essential in preventing the progress of impaired glucose tolerance towards type-2 diabetes [10].
Although the activity of AG in the mucous membrane of the small intestine can be inhibited by commercial AGIs, these pharmaceutical drugs formulated for the inhibition of the key enzymes frequently come with attendant side effects and expensive cost [5,11]. Thus, an economical alternative to managing the disease with few or no side effects is an attractive option. Recent studies on the beneficial health effects of vegetables have piqued the interest of researchers due to their possible protection against chronic diseases. In addition, continuous effort is being made in the research and discovery of new anti-glucosidase/anti-diabetic drugs with higher safety profiles for long-term therapy [12,13,14]. Thus, it is worth reviewing the effects of common vegetables for the purpose of identifying novel/potential compounds that may be suitable for development as anti-diabetes agents. In this review, we will summarize research results on the AGI activity in plants, with emphasis on common vegetables, and also briefly describe possible means of producing vegetables harboring higher levels of AGI activity in the future.
2. Natural Compounds as Potential Candidates for AGIs
A range of chemical compounds identified from various plants shows inhibitory activities against AG enzymes. Most AGIs are secondary metabolites such as alkaloids, phenolic acids, flavonoids, terpenoids, anthocyanins, and their glycosides (Table 1). Alkaloids are mainly found in certain flowering plants [15]. Species from the Berberidaceae family are outstanding alkaloid-yielding plants. However, alkaloids can also be obtained from other sources such as animals, bacteria, and fungi. Plant-derived alkaloids are known to be repellents that protect plants against insects and herbivores. Phenolic compounds are secondary metabolites found most abundantly in plants. Phenolic acids are polyphenols containing the C6 aromatic ring of hydroxybenzoic acids including gallic acid, caffeic acid, and coumaric acid. The synthesis of phenolic compounds in plants is promoted by biotic and abiotic stresses (i.e., herbivores, pathogens, saline stress, heavy metal stress, unfavorable temperature, pH, and UV radiation) [16]. Flavonoids are also polyphenols which present in distinct tissues and organs in various plant species. It has been reported that flavonoids help plants to protect against adverse environmental constraints and also contribute to the growth and development of plants [17]. Terpenes are the most diverse natural products and are formed by a linear arrangement of a single building block called isoprene, also known as 2-methylbuta-1, 3-diene (C5H8). Plants employ terpenoid metabolites for a variety of fundamental functions in growth and development and also use the majority of terpenoids for their protection in the abiotic and biotic environment [18]. From these classes of compounds, a number of individual compounds are reported to show AGI activity because of the special structure or functional groups they possess (Table 1). In addition to the use of secondary metabolites, efforts to explore and develop peptide-based anti-diabetic agents against mammalian intestinal AG are underway [19]. Although the natural substrates of glycosidase are polysaccharides, peptide modulators of AG may have huge potential based on structural features of AGIs with the characteristic sugar-mimetic structure [19,20]. Furthermore, their high affinity and specificity in interactions with the protein targets, and reduced immunogenicity and low toxicity profiles, in general, would be additional benefits of peptide-based AGIs [20]. Iminosugars are another class of compounds that inhibit carbohydrate hydrolyzing enzymes [21,22]. These are sometimes called sugar-shaped alkaloids, polyhydroxy alkaloids, azasugars, or aminosugars due to their structural similarity with sugars [23]. Nojirimycin and fagomine were the first natural iminosugars to be discovered from microbe (Streptomyces) and plant (Fagopyrum esculentum). Iminosugars play an important role in chemotaxonomy and exhibit antimicrobial properties. Moreover, nojirimycin showed potent AG inhibitory activity, which could be due to its structural resemblance to glucose.
Table 1.
Classes of Compound | Chemical Structure | IC50 Value | Reference |
---|---|---|---|
Alkaloids | |||
Vasicine | 125 µM (0.8 µM) |
[24] | |
Piperumbellactam B | 43.8 µM (426 µM) |
[25] | |
Piperumbellactam C | 29.6 µM (426 µM) |
||
Flavonoids | |||
Quercetin | 7 µM | [26] | |
Luteolin | 21 µM | ||
Cyanidin | 4 µM | ||
Baicalein | 0.26 µM (0.02 µM)a |
[27] | |
Quercitrin (quercetin-3-O-α-l-rhamnopyranoside | ~0.5 mM (0.90 mM) |
[28] | |
Isoquercetin | 64.1 ± 3.3 µM (1.50 ± 0.14 µM) Maltase 42.5 ± 1.2 µM (2.38 ± 0.02 µM) Sucrase |
[29] | |
Cyanidin-diglucoside | 14.7 µg/mL | [30] | |
Pelargonidin-3-rutinoside | 64.5 µg/mL | ||
Epicatechin-(4β,8)-Epicatechin gallate | 0.31 µM (5.3 µM) |
[31] | |
Epicatechingallate | 0.71 µM (5.3 µM) |
||
Terpense | |||
22α-hydroxychiisanoside | 819.7 µM (788.6 µM) |
[32] | |
7β-acetoxy-6β-hydroxyroyleanone | 108.2 µM (131.2 µM) |
[33] | |
Spicatanol | 34.1 µM (23.8 µM) |
[34] | |
Lupeol | 7.18 µg/mL (9.68 µg/mL) |
[35] | |
Phenols | |||
p-hydroxycinnamic acid | 90.8 µg/mL (230.4 µg/mL) |
[36] | |
Protocatechuic acid | 85.1 µg/mL (230.4 µg/mL) |
||
Trans-N-(p-Coumaroyl)tyramine | 4.47 µM (168.95 µM) |
[37] | |
2,4-dimethoxy-6,7-dihydroxyphenanthrene | 0.40 mM (3.52 mM) |
[38] | |
Ferulic acid | 4.9 mM (1.7 mM) |
[39] | |
Ellagic acid | 18.4 µg/mL | [30] | |
Umbelliferone | 7.08 µg/mL (9.68 µg/mL) |
[34] | |
Iminosugars | |||
N-(9′-methoxynonyl)-1-deoxynojirimycin | 0.015 µM | [40] | |
N-(6′-4″-azido-2″-nitrophenylamino) hexyl-1-deoxynojirimycin | 0.017 µM |
Values in parentheses are those of positive controls in references. a Concentration of a positive control showing 100% inhbition.
3. Plants with AG Inhibitory Activity
Plants are the major source of phytochemicals, and some of these compounds possess different health promoting functions. Various types of these compounds are being isolated from different plant species and studied for their potential to manage type-2 diabetes, and extracts of leaves, roots, barks, and fruits from different medicinal plants, herbs, and other plants are reported to exhibit inhibitory activity against AG [41,42]. A 13-membered ring thiocyclitol (13-MRT) compound isolated from the medicinal tree, Salacia reticulate, used as an antidiabetic, was reported to show potential AGI activity with IC50 values of 0.23 and 0.19 µM against maltase and sucrase enzymes, respectively [43]. Morus alba is another plant species for which AG inhibitory activity has been well-studied [44], and its leaf extracts exhibited AG inhibition activity with an IC50 value of 91.63 µg/mL compared to that of acarbose (IC50: 402.33 µg/mL) [45]. A range of bioactive compounds isolated from the leaves of Mango (Mangifera indica L.) were screened for their inhibitory effect against AG and among them arjunolic acid and actinidic acid exhibited inhibitory activity with IC50 values of 239.60 ± 25.00 and 297.37 ± 8.12 μM, respectively [46]. Similarly, extracts from the peel of fruits of Jackfruit (Artocarpus heterophyllus) displayed the strongest inhibitory activity (IC50: 0.05 mg/mL) followed by its seed (IC50: 1.79 ± 0.15 mg/mL), pulp (IC50: 6.81 ± 0.52 mg/mL), and flake (IC50: 10.52 ± 0.73 mg/mL) extracts [47]. Grape seed and green tea extracts were also found to have strong inhibitory activity against AG with an IC50 values of 1.2 ± 0.2 and 0.5 ± 0.1 µg/mL, respectively. These inhibition potencies were much stronger than the inhibitory effect obtained from acarbose (IC50: 91.0 ± 10.8 µg/mL) [48].
4. Common Vegetables with AG Inhibitory Activities
Major vegetables belonging to the Solanaceae family, such as pepper, tomato, eggplant, and potato, have been studied for their inhibitory activity against AG enzymes. Water extracts from the fruits of several pepper lines were examined for their effects on AG enzymes and the inhibitory percentages from a red sweet pepper variety were found to be 57% and 48% against yeast and rat AG enzymes, respectively [49]. Similarly, ethanol and water crude extracts from fruits of some pepper cultivars consumed in Korea exhibited close to full inhibitory activity against yeast AGs, compared to acarbose that showed 50% inhibition at 25 mM [50]. Luteolin-7-O-glucoside flavonoid isolated from pepper leaves showed a similar level of inhibitory activity (IC50: 15 µM) compared to acarbose [51]. Recently, methanolic extracts of several potato tubers exhibited AG inhibition with IC50 values ranging from 42.42 ± 0.94 to 78.65 ± 0.48 µg/mL, which is less potent than acarbose (IC50: 15.65 µg/mL) [52]. Fruit extracts from two eggplant species S. macrocarpon and S. melongena exhibited a moderate inhibitory effect with IC50 values of 71.77 ± 0.50 and 63.24 ± 0.30 µg/mL, respectively [53]. Tomato leaf extracts were found to have much milder inhibitory activity (IC50: 1.14 to 6.48 mg/mL) against AGs than that of acarbose (IC50: 356 ± 20.6 µg/mL) [54]. The inhibitory potential of onions together with different vegetables against AGs was also investigated. The ethanol extract of onion powder displayed an average of 74.0% inhibition compared to bitter melon (36.7%), yam (27.2%), and pumpkin (25.2%) [55]. Ethyl acetate extracts obtained from shallot (Allium cepa ascalonicum) peels, peeled bulbs, and bulbs (the whole bulbs) exhibited strong AG inhibitory activity with an IC50 values of 0.012 ± 0.002, 0.035 ± 0.01, and 0.052 ± 0.01 mg/mL, respectively. In the study, the inhibitory activity obtained from the peel was found to be the highest compared to those from different parts of 25 different plant species, including Rheum palmatum roots (IC50: 0.016 ± 0.0002 mg/mL), Cinnamomum zeylanicum bark (IC50: 0.018 ± 0.0006 mg/mL), Brassica juncea leaves (IC50: 0.21 ± 0.02 mg/mL), Capsicum frutescens fruits (IC50: 2.12 ± 0.4 mg/mL), Allium sativum bulbs (IC50: 2.51 ± 0.5 mg/mL), Actinidia deliciosa peels (IC50: 2.77 ± 2.4 mg/mL), and Glycine max beans (IC50: 12.83 ± 4.0 mg/mL) [56].
Natural acylated anthocyanins extracted from Ipomoea batatas showed strong maltase inhibitory activity with an IC50 value of 0.36 mg/mL [57]. Similarly, red cabbage varieties exhibited increased AGI activity, with total highest phenolic and diacylated anthocyanin activity obtained from the Koda variety (with an IC50 value of 3.87 ± 0.12 mg/mL) [58]. Aqueous radish sprout extract was also reported to cause 50% reduction of AG activity at the concentration of 60.7 ± 1.2 mg/mL [59]. Lactucaxanthin, a carotenoid extracted from lettuce, showed AG inhibition with an IC50 value of 1.84 mg/mL, while acarbose showed a value of 16.19 μg/mL [60]. Cucurbits are another major vegetable crops that possess inhibitory activity against AG enzymes. Bitter melon has been proved for hypoglycemic effects. Notably, protein extract from two genotypes of bitter melon (Momordica charantia var. charantia and M. charantia var. muricata) displayed 68.8% and 69.2% inhibition on AG activity, respectively. In the study, the IC50 values of M. charantia var. charantia (0.298 ± 0.034 mg/mL) and M. charantia var. muricata (0.292 ± 0.022 mg/mL) were not significantly different from the IC50 value of acarbose (0.28 ± 0.019 mg/mL) [61]. Likewise, methanol extracts from bitter melon fruits exhibited 50% inhibition on sucrase activity [62] and ethyl acetate extracts of M. charantia showed the highest AG inhibition activity (66.64% ± 2.94%) compared to Trichosanthes cucumerina (Snake gourd: 61.91% ± 1.96%), Lagenaria siceraria (56.04% ± 1.72%), Sechium edule (51.49% ± 2.13%), Benincasa hispida (48.73% ± 0.98%), Luffa acutangula (43.93% ± 1.28%), and Cucurbita maxima (22.11% ± 0.90%) [63]. Extracts from different parts of yellow fleshed watermelon also reduced the activity of AG enzyme; the highest inhibitory activity was obtained from 70% ethanol extract of the leaf (IC50: 26.26 ± 0.29 μg/mL), followed by the seed (IC50: 32.50 ± 0.36 μg/mL), the flesh (IC50: 41.38 ± 1.04 μg/mL), and the rind (IC50: 45.44 ± 0.18 μg/mL) [64]. The aqueous extracts from okra (Abelmoschus esculentus) peels and seeds demonstrated inhibitory effect against glucosidase enzymes with an IC50 value of 142.69 ± 0.32 and 150.47 ± 0.28 μg/mL, respectively [65].
5. Analyses of AGI Activities in Plants
Generally, AGI analysis is an enzymatic assay that follows the same basic principles as most enzymatic assays. Mostly, measurement of AG inhibitory activity is based on colorimetric methods. p-nitrophenyl-α-d-glucopyranoside (pNPG) is a synthetic substrate that is hydrolyzed specifically by AGs into a yellow colour product (4-nitrophenol) that is usually quantified at 405 nm. Hence, measuring the amount of 4-nitrophenol produced from pNPG in the presence or absence of inhibitors is used to measure the inhibitory activity of plant compounds against AGs (Figure 3A; [66]). Similarly, several studies have used maltose or sucrose as a substrate to screen the inhibitory potential of plant extracts against AG enzymes based on the amount of glucose produced in the presence or absence of the inhibitors (Figure 3B; [67,68,69]). However, even though the measurement methods look similar, there is inconsistency in the choice of enzyme sources, concentration of enzymes and substrates, and sometimes incubation time, which result in variations in absolute values. Therefore, well-known AGI compounds are usually used as controls for comparison of the inhibitory potency of other inhibitors against AG enzymes. However, these inhibitors usually exhibit different inhibitory activities based on the origin of glucosidase enzymes. The representative AG inhibitors such as acarbose and glucono-1, 5-lactone inhibited enzymes obtained from rat, rabbit, and pig intestine but had no inhibitory effects on baker’s yeast AG enzyme. On the contrary, (+)-catechin exhibited good inhibition against yeast AG without significant inhibitory effects on the mammalian enzymes [67]. Moreover, acarbose and voglibose showed no inhibition against AG from yeast and Bacillus stearothermophilus, but they inhibited porcine small intestinal AG with IC50 values of 35.00 and 0.035 μg/mL, respectively [66]. However, acarbose has been used as a positive control for modest inhibition against the yeast AG enzyme activity in several cases. Of note, there are independent reports demonstrating that acarbose exhibited 50% inhibition of yeast enzyme activity at the concentration of 177.47 ± 6.28 μg/mL [70] and 200 μg/mL [71]. Therefore, apart from the inherent difference in inhibitor’s affinity toward different AG enzymes, other conditions in assays could also cause inconsistency of inhibitors’ potency. For example, concentrations of enzymes and substrates were reported to affect IC50 values of particular competitive inhibitors. Thus, determination of an inhibition constant (Ki) as a measure of absolute binding affinity would solve this matter as it is not affected either by substrate or enzyme concentrations [72]. In addition, the concentration of substrates should be around their Km values toward an enzyme in order to screen all types of inhibitors, such as competitive, non-competitive, and mixed type inhibitors [73].
6. Production of Vegetables with Higher AGI Activity
Very few vegetables have been released/commercialized with approval of ingredients to help in managing type-2 diabetes. “Dangjo” and “Wongi No. 1” are two well-known Korean pepper varieties that have been specifically developed for higher AGI activity [51,74]. Since a range of bioactive compounds have been reported to possess AG inhibitory activity, as described above, increasing the amount of such inhibitors in vegetables can be a critical step for the production of vegetables with higher AGI activity. Most AGI activities are associated with the genetic architecture of quantitative traits (secondary metabolites; [75]). Thus, conventional breeding methods based on selection or hybridization with the aid of chemical analytical tools can also be used to produce vegetables with increased amounts of AGIs. It has been reported that various vegetables contain bioactive metabolic compounds (Table 2) and varieties/cultivars with higher content of AG inhibitory compounds from each species can be also generated through molecular breeding and/or biotechnological approaches. Genetic analyses of gene interactions and heritability for these compounds are necessary to establish appropriate breeding programs. However, few studies have reported the genetic parameters linked to the quantitative analyses of secondary metabolites including phenolic acids, flavonoids, alkaloids, and terpenes. A recent report of moderate to high heritability values for chlorogenic acid content in eggplants indicates that selection for these traits is likely to be a stepping stone for launching efficient breeding programs targeting production of vegetables with improved content of bioactive compounds [76].
Table 2.
Recent advances in molecular biology and genomics have given new insight into the biosynthesis pathways of secondary metabolites, including phenolic acids and flavonoids, and allowed the identification of quantitative trait loci (QTLs) involved in the pathways. A number of metabolic quantitative trait loci (mQTLs) and candidate genes responsible for the synthesis of phenolic acids were identified in a population generated from an interspecific cross between S. lycopersicum and S. Chmielowski [85]. Based on the knowledge gained by genetic/genomic approaches, vegetables with an increased amount of such compounds via enhanced biosynthesis can be produced through genetic transformation. For instance, co-introduction of the PRODUCTION OF ANTHOCYANIN PIGMENT1 (PAP1), a regulatory gene from Arabidopsis, and the CHALCONE ISOMERASE (CHI) gene, from Allium cepa, into tomato caused 130- and 30-times higher levels of rutin (a bioactive flavonol) and total anthocyanin content, respectively, than those found in wild tomato skin [86].
7. Future Perspectives
Diverse groups of secondary metabolites exist in plants and the current technologies in analytical chemistry as well as biochemistry provide opportunities to develop efficient high-throughput screening methods for compounds with AGI activity. Considerable effort has also been put into producing common vegetables containing higher amounts of AG inhibitory compounds. In addition, the content of AGIs in vegetables can be increased by controlling environmental factors for plant growth and development, such as temperature, light (i.e., period and quality), nutrients, water availability, and so on. A generation of new varieties with higher AG inhibitory compound content is also attainable through breeding with the aid of molecular genetic technologies. Current advances in molecular genetic/genomic technologies, followed by the availability of plant genomic and/or metabolomic information, has made it possible to acquire precise profiles of AGI candidates and even to identify the genes responsible for their biosynthesis. Genome editing (GE) technologies including CRISPR/Cas9 systems are also likely to be utilized for enhanced production of AG inhibitory compounds in common vegetables (Figure 4). We believe that production of vegetables with higher AGI activity would be of great help in treatment/management of type-2 diabetes, since vegetables are rich in fiber and/or are high in nitrates, and will generally support improved levels of healthy cholesterol and lower blood pressure. Additionally, adverse effects of AGIs, such as flatulence, abdominal discomfort, and diarrhea, can be reduced since they are generally dependent on AGIs dosage and duration of therapy/treatment. However, the goal—production of common vegetables with desirable AG inhibitory compound content—should be achieved without compromising crop yield, quality, and customers’ preference.
Acknowledgments
We thank the anonymous reviewers for their careful reading of our manuscript and their insightful comments and suggestions.
Author Contributions
Conceptualization, S.T.A. and S.J.; resources, S.-Y.C. and M.-C.C.; writing—original draft preparation, S.T.A. and S.J.; writing—review and editing, S.T.A.; E.-Y.Y.; M.S.; J.L.; S.J.; supervision, S.J.; funding acquisition, M.-C.C. and S.J. All authors have read and agreed to the published version of the manuscript.
Funding
This work was supported in part by a grant from the World Vegetable Center Korea Office (WKO #10000379); core donors to the World Vegetable Center: Republic of China (ROC), UK aid from the UK government, United States Agency for International Development (USAID), Australian Center for International Agricultural Research (ACIAR), Germany, Thailand, Philippines, Korea and Japan, and a grant from Rural Development Administration, Republic of Korea [Cooperative Research Program for Agriculture Science and Technology Development (Project No. PJ01324302)].
Conflicts of Interest
The authors declare that there are no conflicts of interest regarding the publication of this article.
References
- 1.Davies G.J., Gloster T.M., Henrissat B. Recent structural insights into the expanding world of carbohydrate-active enzymes. Curr. Opin. Struct. Biol. 2005;15:637–645. doi: 10.1016/j.sbi.2005.10.008. [DOI] [PubMed] [Google Scholar]
- 2.Vocadlo D.J., Davies G.J. Mechanistic insights into glycosidase chemistry. Curr. Opin. Chem. Biol. 2008;12:539–555. doi: 10.1016/j.cbpa.2008.05.010. [DOI] [PubMed] [Google Scholar]
- 3.Kajimoto T., Node M. Inhibitors against glycosidases as medicines. Curr. Top. Med. Chem. 2009;9:13–33. doi: 10.2174/156802609787354333. [DOI] [PubMed] [Google Scholar]
- 4.Stutz A.E., Wrodnigg T.M. Imino sugars and glycosyl hydrolases: Historical context, current aspects, emerging trends. Adv. Carbohydr. Chem. Biochem. 2011;66:187–298. doi: 10.1016/B978-0-12-385518-3.00004-3. [DOI] [PubMed] [Google Scholar]
- 5.Bischoff H. Pharmacology of alpha-glucosidase inhibition. Eur. J. Clin. Investig. 1994;24:3–10. [PubMed] [Google Scholar]
- 6.Chiba S. Molecular mechanism in alpha-glucosidase and glucoamylase. Biosci. Biotechnol. Biochem. 1997;61:1233–1239. doi: 10.1271/bbb.61.1233. [DOI] [PubMed] [Google Scholar]
- 7.Meneilly G.S., Ryan E.A., Radziuk J., Lau D.C., Yale J.F., Morais J., Chiasson J.L., Rabasa-Lhoret R., Maheux P., Tessier D., et al. Effect of acarbose on insulin sensitivity in elderly patients with diabetes. Diabetes Care. 2000;23:1162. doi: 10.2337/diacare.23.8.1162. [DOI] [PubMed] [Google Scholar]
- 8.Truscheit E., Hillebrand I., Junge B., Müller L., Puls W., Schmidt D. Drug Concentration Monitoring Microbial Alpha-Glucosidase Inhibitors Plasminogen Activators. Volume 7 Springer; Berlin/Heidelberg, Germany: 1988. Microbial α-Glucosidase Inhibitors: Chemistry, Biochemistry, and Therapeutic Potential. Progress in Clinical Biochemistry and Medicine. [Google Scholar]
- 9.Proença C., Freitas M., Ribeiro D., Oliveira E.F.T., Sousa J.L.C., Tomé S.M., Ramos M.J., Silva A.M.S., Fernandes P.A., Fernandes E. α-Glucosidase inhibition by flavonoids: An in vitro and in silico structure–activity relationship study. J. Enzym. Inhib. Med. Chem. 2017;32:1216–1228. doi: 10.1080/14756366.2017.1368503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sugihara H., Nagao M., Harada T., Nakajima Y., Tanimura-Inagaki K., Okajima F., Tamura H., Inazawa T., Otonari T., Kawakami M., et al. Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes. J. Diabetes Investig. 2014;5:206–212. doi: 10.1111/jdi.12135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Adefegha S.A., Oboh G. Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside-induced lipid peroxidation in rat pancreas by water extractable phytochemicals from some tropical spices. Pharm. Biol. 2012;50:857–865. doi: 10.3109/13880209.2011.641022. [DOI] [PubMed] [Google Scholar]
- 12.Udenigwe C.C., Adebiyi A.P., Doyen A., Bazinet L., Aluko R.E. Low molecular weight flaxseed protein-derived arginine-containing peptides reduced blood pressure of spontaneously hypertensive rats faster than amino acid form of arginine and native flaxseed protein. Food Chem. 2012;132:468–475. doi: 10.1016/j.foodchem.2011.11.024. [DOI] [PubMed] [Google Scholar]
- 13.Spiller H.A., Sawyer T.S. Toxicology of oral antidiabetic medications. Am. J. Health Syst. Pharm. 2006;63:929–938. doi: 10.2146/ajhp050500. [DOI] [PubMed] [Google Scholar]
- 14.Liu Z., Ma S. Recent advances in synthetic α-glucosidase inhibitors. Chem. Med. Chem. 2017;12:819–829. doi: 10.1002/cmdc.201700216. [DOI] [PubMed] [Google Scholar]
- 15.Girdhar S., Girdhar A., Verma S.K., Lather V., Pandita D. Plant derived alkaloids in major neurodegenerative diseases: From animal models to clinical trials. J. Ayurvedic Herb. Med. 2015;1:91–100. [Google Scholar]
- 16.Lin D., Xiao M., Zhao J., Li Z., Xing B., Li X., Kong M., Li L., Zhang Q., Liu Y., et al. An Overview of Plant Phenolic Compounds and Their Importance in Human Nutrition and Management of Type 2 Diabetes. Molecules. 2016;21:1374. doi: 10.3390/molecules21101374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Falcone-Ferreyra M.L., Rius S.P., Casati P. Flavonoids: Biosynthesis, biological functions, and biotechnological applications. Front. Plant Sci. 2012;3:222. doi: 10.3389/fpls.2012.00222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tholl D. Biosynthesis and biological functions of terpenoids in plants. Adv. Biochem. Eng. Biotechnol. 2015;148:63–106. doi: 10.1007/10_2014_295. [DOI] [PubMed] [Google Scholar]
- 19.Roskar I., Molek P., Vodnik M., Stempelj M., Strukelj B., Lunder M. Peptide modulators of alpha-glucosidase. J. Diabetes Investig. 2015;6:625–631. doi: 10.1111/jdi.12358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Moorthy N.S., Ramos M.J., Fernandes P.A. Studies on alpha-glucosidase inhibitors development: Magic molecules for the treatment of carbohydrate mediated diseases. Mini Rev. Med. Chem. 2012;12:713–720. doi: 10.2174/138955712801264837. [DOI] [PubMed] [Google Scholar]
- 21.Zechel D.L., Boraston A.B., Gloster T., Boraston C.M., Macdonald J.M., Tilbrook D.M., Stick R.V., Davies G.J. Iminosugar glycosidase inhibitors: Structural and thermodynamic dissection of the binding of isofagomine and 1-deoxynojirimycin to beta-glucosidases. J. Am. Chem. Soc. 2003;125:14313–14323. doi: 10.1021/ja036833h. [DOI] [PubMed] [Google Scholar]
- 22.Wang R.W., Qiu X.L., Bols M., Caballero F.O., Qing F.L. Synthesis and biological evaluation of glycosidase inhibitors: Gem-Difluoromethylenated Nojirimycin analogues. J. Med. Chem. 2006;49:2989–2997. doi: 10.1021/jm060066q. [DOI] [PubMed] [Google Scholar]
- 23.Stiitz E.A. Iminosugars as Glycosidase Inhibitors Nojirimycin and Beyond. Wiley-VCH Verlag GmbH; Weinheim, Germany: 1999. [Google Scholar]
- 24.Gao H., Huang Y.N., Gao B., Li P., Inagaki C., Kawabata J. Inhibitory effect on α-glucosidase by Adhatoda vasica Nees. Food Chem. 2008;108:965–972. doi: 10.1016/j.foodchem.2007.12.002. [DOI] [PubMed] [Google Scholar]
- 25.Tabopda T.K., Ngoupayo J., Liu J., Mitaine-Offer A.C., Tanoli S.A., Khan S.N., Ali M.S., Ngadjui B.T., Tsamo E., Lacaille-Dubois M.A., et al. Bioactive aristolactams from Piper umbellatum. Phytochemistry. 2008;69:1726–1731. doi: 10.1016/j.phytochem.2008.02.018. [DOI] [PubMed] [Google Scholar]
- 26.Tadera K., Minami Y., Takamatsu K., Matsuoka T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J. Nutr. Sci. Vitaminol. (Tokyo) 2006;52:149–153. doi: 10.3177/jnsv.52.149. [DOI] [PubMed] [Google Scholar]
- 27.Kumar S., Narwal S., Kumar V., Prakash O. Alpha-glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharmacogn. Rev. 2011;5:19–29. doi: 10.4103/0973-7847.79096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Schmidt J.S., Lauridsen M.B., Dragsted L.O., Nielsen J., Staerk D. Development of a bioassay-coupled HPLC-SPE-ttNMR platform for identification of α-glucosidase inhibitors in apple peel (Malus x domestica Borkh.) Food Chem. 2012;135:1692–1699. doi: 10.1016/j.foodchem.2012.05.075. [DOI] [PubMed] [Google Scholar]
- 29.Thanakosaia W., Phuwapraisirisanb P. First identification of α-glucosidase inhibitors from Okra (Abelmoschus esculentus) Seeds. Nat. Prod. Commun. 2013;8:1085–1088. doi: 10.1177/1934578X1300800813. [DOI] [PubMed] [Google Scholar]
- 30.Zhang L., Li J., Hogan S., Chung H., Welbaum G.E., Zhou K. Inhibitory effect of raspberries on starch digestive enzyme and their antioxidant properties and phenolic composition. Food Chem. 2010;119:592–599. doi: 10.1016/j.foodchem.2009.06.063. [DOI] [Google Scholar]
- 31.Chu Y.H., Wu S.H., Hsieh J.F. Isolation and characterization of α-glucosidase inhibitory constituents from Rhodiola crenulata. Food Res. Int. 2014;57:8–14. doi: 10.1016/j.foodres.2014.01.029. [DOI] [Google Scholar]
- 32.Wang Z.B., Jiang H., Xia Y.G., Yang B.Y., Kuang H.X. Alpha-glucosidase inhibitory constituents from Acanthopanax senticosus harm leaves. Molecules. 2012;17:6269–6276. doi: 10.3390/molecules17066269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kubínová B.R., Pořízková R., Navrátilová A., Farsa O., Hanáková Z., Bačinská A., Čížek A., Valentová M. Antimicrobial and enzyme inhibitory activities of the constituents of Plectranthus madagascariensis (Pers) J. Enzym. Inhib. Med. Chem. 2014;29:749–752. doi: 10.3109/14756366.2013.848204. [DOI] [PubMed] [Google Scholar]
- 34.Reddy P., Ashok P., Tiwari K., Rao R.R., Madhusudhana K., Rao V.R., Ali A.Z., Babu K.S., Rao J.M. New Labdane diterpenes as intestinal α-glucosidase inhibitor from anti hyperglycemic extract of Hedychium spicatum (Ham. Ex Smith) rhizomes. Bioorg. Med. Chem. Lett. 2009;19:2562–2565. doi: 10.1016/j.bmcl.2009.03.045. [DOI] [PubMed] [Google Scholar]
- 35.Ramu R., Shirahatti P.S., Zameer F., Ranganatha L.V., Prasad M.N. Inhibitory effect of banana (Musa sp. var. Nanjangud rasa bale) flower extract and its constituents Umbelliferone and Lupeol on α-glucosidase, aldose reductase and glycation at multiple stages. S. Afr. J. Bot. 2014;95:54–63. doi: 10.1016/j.sajb.2014.08.001. [DOI] [Google Scholar]
- 36.Nile S.H., Park S.W. Antioxidant, α-glucosidase and xanthine oxidase inhibitory activity of bioactive compounds from maize (Zea mays L.) Chem. Biol. Drug Des. 2014;83:119–125. doi: 10.1111/cbdd.12205. [DOI] [PubMed] [Google Scholar]
- 37.Zhang L., Tu Z., Yuan T., Wang H., Xie X., Fu Z. Antioxidants and α-glucosidase inhibitors from Ipomoea batatas leaves identified by bioassay-guided approach and structure-activity relationships. Food Chem. 2016;208:61–67. doi: 10.1016/j.foodchem.2016.03.079. [DOI] [PubMed] [Google Scholar]
- 38.Zhang S.S., Wu D., Li H., Zhu J., Hu W., Lua M., Liu X. Rapid identification of α-glucosidase inhibitors from Dioscorea opposita Thunb peel extract by enzyme functionalized Fe3O4 magnetic nanoparticles coupled with HPLC-MS/MS. Food Funct. 2017;8:3219–3227. doi: 10.1039/C7FO00928C. [DOI] [PubMed] [Google Scholar]
- 39.Jeong E.Y., Cho K.S., Lee H.S. α-Amylase and α-Glucosidase Inhibitors Isolated from Triticum aestivum L. Sprouts. J. Korean Soc. Appl. Biol. Chem. 2012;55:47–51. doi: 10.1007/s13765-012-0008-1. [DOI] [Google Scholar]
- 40.Alonzi D.S., Scott K.A., Dwek R.A., Zitzmann N. Iminosugar antivirals: The therapeutic sweet spot. Biochem. Soc. Trans. 2017;45:571–582. doi: 10.1042/BST20160182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Yin Z., Zhang W., Feng F., Zhang Y., Kang W. α-Glucosidase inhibitors isolated from medicinal plants. Food Sci. Hum. Wellness. 2014;3:136–174. doi: 10.1016/j.fshw.2014.11.003. [DOI] [Google Scholar]
- 42.Kawada Y., Miura M., Gomyo T. Inhibitory Effect of Vegetables, Fruits and Herbs on α-Glucosidase in an Immobilized Enzyme Assay System. Food Sci. Technol. Res. 2006;12:275–277. doi: 10.3136/fstr.12.275. [DOI] [Google Scholar]
- 43.Oe H., Ozaki S. Hypoglycemic Effect of 13-Membered Ring Thiocyclitol, a Novel α-Glucosidase Inhibitor from Kothala-himbutu (Salacia reticulata) Biosci. Biotechnol. Biochem. 2008;72:1962–1964. doi: 10.1271/bbb.80118. [DOI] [PubMed] [Google Scholar]
- 44.Wafaa B., Said B., Mohamed B. Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors. Curr. Diabetes Rev. 2010;6:247–254. doi: 10.2174/157339910791658826. [DOI] [PubMed] [Google Scholar]
- 45.Hwang S.H., Li H.M., Lim S.S., Wang Z., Hong J.S., Huang B. Evaluation of a standardized extract from Morus alba against α-glucosidase inhibitory effect and postprandial anti hyperglycemic in patients with impaired glucose tolerance: A randomized double-blind clinical trial. Evid. Based Complement. Altern. Med. 2016:1–10. doi: 10.1155/2016/8983232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Pan J., Yi X., Wang Y., Chen G., He X. Benzophenones from Mango Leaves Exhibit α-Glucosidase and NO Inhibitory Activities. J. Agric. Food Chem. 2016;64:7475–7480. doi: 10.1021/acs.jafc.6b02404. [DOI] [PubMed] [Google Scholar]
- 47.Zhang L., Tu Z., Xie X., Wang H., Wang H., Wang Z., Sha X., Lua Y. Jackfruit (Artocarpus heterophyllus Lam.) peel: A better source of antioxidants and α-glucosidase inhibitors than pulp, flake and seed, and phytochemical profile by HPLC-QTOF-MS/MS. Food Chem. 2017;234:303–313. doi: 10.1016/j.foodchem.2017.05.003. [DOI] [PubMed] [Google Scholar]
- 48.Musa M.Y., Griffith A.M., Michels A.J., Schneider E., Frei B. Grape seed and tea extracts and catechin 3-gallates are potent inhibitors of α-amylase and α-glucosidase activity. J. Agric. Food Chem. 2012;60:8924–8929. doi: 10.1021/jf301147n. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Kwon Y.I., Apostolidis E., Shetty K. Evaluation of pepper (Capsicum annuum) for management of diabetes and hypertension. J. Food Biochem. 2007;31:370–385. doi: 10.1111/j.1745-4514.2007.00120.x. [DOI] [Google Scholar]
- 50.Kim Y.C., Choi D., Lee J.H., Lee S. Alpha-glucosidase inhibitory activity in different pepper cultivars (Capsicum annuum L.) Hortic. Sci. Technol. 2018;36:444–450. [Google Scholar]
- 51.Park M.S., Zhu Y.X., Pae H.O., Park S.H. In vitro and in vivo α-glucosidase and α-amylase inhibitory effects of the water extract of leaves of pepper (Capsicum annuum L. Cultivar Dangjo) and the active constituent luteolin 7-O-glucoside. J. Food Biochem. 2016;40:696–703. doi: 10.1111/jfbc.12252. [DOI] [Google Scholar]
- 52.Kalita D., Holm D.G., LaBarbera D.V., Petrash J.M., Jayanty S.S. Inhibition of α-glucosidase, α-amylase, and aldose reductase by potato polyphenolic compounds. PLoS ONE. 2018;13:e0191025. doi: 10.1371/journal.pone.0191025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Nwanna E.E., Ibukun E.O., Oboh G. Inhibitory effects of methanolic extracts of two eggplant species from South-western Nigeria on starch hydrolysing enzymes linked to type-2 diabetes. Afr. J. Pharm. Pharmacol. 2013;7:1575–1584. doi: 10.5897/AJPP2013.3606. [DOI] [Google Scholar]
- 54.Figueiredo-González M., Valentão P., Andrade P.B. Tomato plant leaves: From by-products to the management ofenzymes in chronic diseases. Ind. Crops Prod. 2016;94:621–629. doi: 10.1016/j.indcrop.2016.09.036. [DOI] [Google Scholar]
- 55.Wu H., Xu B. Inhibitory Effects of Onion against α-Glucosidase Activity and its Correlation with Phenolic Antioxidants. Int. J. Food Prop. 2014;17:599–609. doi: 10.1080/10942912.2012.654562. [DOI] [Google Scholar]
- 56.Kongstad K.T., Özdemir C., Barzak A., Wubshet S.G., Staerk D. Combined use of high-resolution α-glucosidase inhibition profiling and high-performance liquid chromatography−high-resolution mass spectrometry−solid-phase extraction−nuclear magnetic resonance spectroscopy for investigation of antidiabetic principles in crude plant extracts. J. Agric. Food Chem. 2015;63:2257–2263. doi: 10.1021/jf506297k. [DOI] [PubMed] [Google Scholar]
- 57.Matsui T., Ueda T., Oki T., Sugita K., Terahara N., Matsumoto K. Alpha-glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigment with potent inhibitory activity. J. Agric. Food Chem. 2001;49:1948–1951. doi: 10.1021/jf001251u. [DOI] [PubMed] [Google Scholar]
- 58.Podsędek A., Majewska I., Kucharska A.Z. Inhibitory potential of red cabbage against digestive enzymes linked to obesity and type 2 diabetes. J. Agric. Food Chem. 2017;65:7192–7199. doi: 10.1021/acs.jafc.7b02499. [DOI] [PubMed] [Google Scholar]
- 59.Baenas N., Piegholdt S., Schloesser A., Moreno D.A., Viguera C.G., Rimbach G., Wagner A.E. Metabolic activity of radish sprouts derived isothiocyanates in Drosophila melanogaster. Int. J. Mol. Sci. 2016;17:251. doi: 10.3390/ijms17020251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Gopal S.S., Lakshmi M.J., Sharavana G., Sathaiah G., Sreeramac Y.N., Baskaran V. Lactucaxanthin—A potential anti-diabetic carotenoid from lettuce (Lactuca sativa) inhibits α-amylase and α-glucosidase activity in vitro and in diabetic rats. Food Funct. 2017;8:1124–1131. doi: 10.1039/C6FO01655C. [DOI] [PubMed] [Google Scholar]
- 61.Poovitha S., Parani M. In vitro and in vivo α-amylase and α- glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.) BMC Complement. Altern. Med. 2016;16(Suppl. 1):185. doi: 10.1186/s12906-016-1085-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Uebanso T., Arai H., Taketani Y., Fukaya M., Yamamoto H., Mizuno A., Uryu K., Hada T., Takeda E. Extracts of Momordica charantia suppress postprandial hyperglycemia in rats. J. Nutr. Sci. Vitaminol. 2007;53:482–488. doi: 10.3177/jnsv.53.482. [DOI] [PubMed] [Google Scholar]
- 63.Sulaiman S.F., Ooi K.L. Antioxidant and α-glucosidase inhibitory activities of cucurbit fruit vegetables and identification of active and major constituents from phenolic-rich extracts of Lagenaria siceraria and Sechium edule. J. Agric. Food Chem. 2013;61:10080–10090. doi: 10.1021/jf4031037. [DOI] [PubMed] [Google Scholar]
- 64.Jibril M.M., Hamid A.A., Ghazali H.M., Dek M.S.P., Ramli N.S., Jaafar A.H., Karrupan J., Mohammed A.S. Antidiabetic antioxidant and phytochemical profile of yellow-fleshed seeded watermelon (Citrullus Lanatus) extracts. J. Food Nut. Res. 2019;7:82–95. [Google Scholar]
- 65.Sabitha V., Panneerselvam K., Ramachandran S. In vitro α-glucosidase and α-amylase enzyme inhibitory effects in aqueous extracts of Abelmoscus esculentus (L.) Moench. Asian Pac. J. Trop. Biomed. 2012;2:S162–S164. doi: 10.1016/S2221-1691(12)60150-6. [DOI] [Google Scholar]
- 66.Kim Y.M., Wang M.H., Rhee H.I. A novel alpha-glucosidase inhibitor from pine bark. Carbohydr. Res. 2004;339:715–717. doi: 10.1016/j.carres.2003.11.005. [DOI] [PubMed] [Google Scholar]
- 67.Oki T., Matusi T., Osajima Y. Inhibitory effect of alpha glucosidase inhibitors varies according to its origin. J. Agric. Food Chem. 1999;47:550–553. doi: 10.1021/jf980788t. [DOI] [PubMed] [Google Scholar]
- 68.Malunga L.N., Eck P., Beta T. Inhibition of intestinal α-glucosidase and glucose absorption by feruloylated arabinoxylan Mono and oligosaccharides from corn bran and wheat aleurone. J. Nutr. Metab. 2016:1932532. doi: 10.1155/2016/1932532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Pyner A., Nyambe-silavwe H., Williamson G. Inhibition of human and rat sucrase and maltase activities to assess antiglycemic potential: Optimization of the assay using acarbose and polyphenols. J. Agric. Food Chem. 2017;65:8643–8651. doi: 10.1021/acs.jafc.7b03678. [DOI] [PubMed] [Google Scholar]
- 70.Zhang H.C., Wang G., Beta T., Dong J. Inhibitory properties of aqueous ethanol extracts of propolis on alpha-glucosidase. Evid. Based Complement. Altern. Med. 2015:587383. doi: 10.1155/2015/587383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Zhang J., Zhao S., Yin P., Yan L., Han J., Shi L., Zhou X., Liu Y., Ma C. α-Glucosidase inhibitory activity of polyphenols from the burs of Castanea mollissima blume. Molecules. 2014;19:8373–8386. doi: 10.3390/molecules19068373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Copeland R.A. Mechanistic considerations in high-throughput screening. Anal. Biochem. 2003;320:1–12. doi: 10.1016/S0003-2697(03)00346-4. [DOI] [PubMed] [Google Scholar]
- 73.Acker M.G., Auld D.S. Consideration for the design and reporting of enzyme assay in high-throughput screening applications. Perspect. Sci. 2014;1:56–73. doi: 10.1016/j.pisc.2013.12.001. [DOI] [Google Scholar]
- 74.Cho M.C., Yang E.Y., Rhee H.I., Chae Y.S., Jeong H.B., Chae Y., Pae H.D., Ko D.K. Breeding of Functional pepper (Capsicum annuum) Variety ‘Wongi No. 1’. Kor. J. Hort. Sci. Technol. 2009;5:82–83. [Google Scholar]
- 75.Kaushik P., Andújar I., Vilanova S., Plazas M., Gramazio P., Herraiz F.J., Brar N.S., Prohens J. Breeding Vegetables with increased content in bioactive phenolic acids. Molecules. 2015;20:18464–18481. doi: 10.3390/molecules201018464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Plazas M., Prohens J., Cuñat N.A., Vilanova S., Gramazio P., Herraiz J.F., Andújar I. Reducing capacity, chlorogenic acid content and biological activity in a collection of scarlet (Solanum aethiopicum) and gboma (S. macrocarpon) eggplants. Int. J. Mol. Sci. 2014;15:17221–17241. doi: 10.3390/ijms151017221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Bhandari S.R., Cho M.C., Lee J.G. Genotypic variation in carotenoid, ascorbic acid, total phenolic, and flavonoid contents, and antioxidant activity in selected tomato breeding lines. Hortic. Environ. Biotechnol. 2016;57:440–452. doi: 10.1007/s13580-016-0144-3. [DOI] [Google Scholar]
- 78.Gurnani N., Gupta M., Mehta D., Mehta B.K. Chemical composition, total phenolic and flavonoid contents, and in vitro antimicrobial and antioxidant activities of crude extracts from red chilli seeds (Capsicum frutescens L.) J. Taibah Univ. Sci. 2016;10:462–470. doi: 10.1016/j.jtusci.2015.06.011. [DOI] [Google Scholar]
- 79.Assefa A.D., Jeong Y.J., Kim D.J., Jeon Y.A., Lee J.R., Ko H.C., Baek H.J., Sung J.S. Assessing phenolic content and antioxidant potential diversity in Allium plants using multivariate data analysis. Hortic. Environ. Biotechnol. 2018;59:759–773. doi: 10.1007/s13580-018-0081-4. [DOI] [Google Scholar]
- 80.Marotti M., Piccagli R. Characterization of flavonoids in different cultivars of Onion (Allium cepa L.) J. Food Sci. 2002;67:1229–1232. doi: 10.1111/j.1365-2621.2002.tb09482.x. [DOI] [Google Scholar]
- 81.Beato V.M., Orgaz F., Mansilla F., Montaño A. Changes in phenolic compounds in garlic (Allium sativum L.) owing to the cultivar and location of growth. Plant Foods Hum. Nutr. 2011;66:218–223. doi: 10.1007/s11130-011-0236-2. [DOI] [PubMed] [Google Scholar]
- 82.Bhandari S.R., Yoon M.K., Kwak J.H. Contents of phytochemical constituents and antioxidant activity of 19 garlic (Allium sativum L.) parental lines and cultivars. Hort. Environ. Biotechnol. 2014;55:138–147. doi: 10.1007/s13580-014-0155-x. [DOI] [Google Scholar]
- 83.Hanson P.M., Yang R.Y., Tsou S.C.S., Ledesma D., Engle L., Lee T.C. Diversity in eggplant (Solanum melongena) for superoxide scavenging activity, total phenolics, and ascorbic acid. J. Food Compos. Anal. 2006;19:594–600. doi: 10.1016/j.jfca.2006.03.001. [DOI] [Google Scholar]
- 84.Kaur C., Nagal S., Nishad J., Kumar R., Sarika J. Evaluating eggplant (Solanum melongena L.) genotypes for bioactive properties: A chemometric approach. Food Res. Int. 2014;60:205–211. doi: 10.1016/j.foodres.2013.09.049. [DOI] [Google Scholar]
- 85.Ballester A.R., Tikunov Y., Molthoff J., Grandillo S., Viquez-Zamora M., de Vos R., de Maagd R.A., van Heusden S., Bovy A.G. Identification of loci affecting accumulation of secondary metabolites in tomato fruit of a Solanum lycopersicum × Solanum chmielewskii introgression line population. Front. Plant Sci. 2016;7:1428. doi: 10.3389/fpls.2016.01428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Lim W., Li J. Synergetic effect of the Onion CHI gene on the PAP1 regulatory gene for enhancing the flavonoid profile of tomato skin. Sci. Rep. 2017;7:12377. doi: 10.1038/s41598-017-12355-x. [DOI] [PMC free article] [PubMed] [Google Scholar]